Abstract:Previous studies demonstrated that Th1 cytokines like IL-2, IL-12 and IFN-γ have initiatory role in alopecia areata (AA) and positive correlation with disease severity. They informed that serum levels of Th17 cytokines, IL-17, IL-22, IL-23 increased in active AA patients and corelated, particularly IL-17, with disease severity. In recent reports it was showed the balance between Th17 and Treg cells is crucial for maintaining tolerance to self-antigens, and an imbalance towards Th17 may contribute to the development of autoimmune diseases like AA. But research on serum Treg markers in AA is limited. It was aimed to investigate whether the Treg cells have a role in the pathogenesis of AA analyzing the serum levels of Treg cytokines IL-35 and TGF-β in the patients with AA. 42 AA patients and 38 healthy controls were enrolled. Patient demographics, clinical data, disease severity assessed by Severity of Alopecia Tool (SALT) scores were recorded. Serum samples were collected and analyzed for TGF-β and IL-35 levels using ELISA kits. The cytokine levels in both groups were statistically compared. Their relation with parameters of demographic and severity of disease was evaluated. The patient and control groups had no statistically significant difference, there was 71.4% males and 28.6% females in patient group, while the control group had 63.2% males and 36.8% females, Severity analysis classified 18 patients with mild AA, 19 with moderate AA, and 5 with alopecia totalis/areata universalis. While TGF-β levels exhibited no significant difference between groups, IL-35 levels were significantly elevated in AA patients (p = 0.002). Logistic regression identified IL-35 as a significant parameter influencing disease status (OR = 1.055). Correlation analysis revealed a weak positive correlation between patient age and IL-35 levels (r = 0.436; p = 0.004). Notably, IL-35 levels displayed a significant decrease in individuals with antinuclear antibody (ANA) positivity. No correlations were identified between cytokine levels and disease severity, prognosis, or disease activity. Elevated IL-35 levels suggest that IL-35 and specific Treg cell subsets can play a role in AA pathogenesis. The nuanced roles of TGF-β and IL-35 highlight the need for comprehensive studies to interpret their implications in the complex immunopathogenesis of AA. These findings open avenues for further research, positioning IL-35 as a prospective target for investigating and potentially intervening in AA pathogenesis.

lmmunohistochemical Analysis of T-cell Subsets in the Peribulbar and lntrabulbar lnfiltrates of Alopecia areata

JAK Inhibitors for the Treatment of Alopecia Areata

Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata

The proliferation and apoptosis of hair follicle stem cells in hair follicle in male patients with androgentic alopecia

Pathogenesis of Alopecia Areata in C3H/He J Mice and DEBR Rats

Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational Modifications

Alopecia Areata: Infiltration of Th17 Cells in the Dermis, Particularly around Hair Follicles

Hair follicle immune privilege and its collapse in alopecia areata

Stratification of alopecia areata reveals involvement of CD4 T cell populations and altered faecal microbiota

Study of IFN- Γ and IL- 10 Levels in Serum of Patients with Alopecia Areata

Evaluation of several immune and inflammatory indicators and their association with alopecia areata

Hair Follicle Melanocytes Initiate Autoimmunity in Alopecia Areata: a Trigger Point

The value of immunohistochemical expression of SOX9 and CD34 in alopecia areata

Myeloid Adherent Cells Are Involved in Hair Loss in the Alopecia Areata Mouse Model

What causes alopecia areata?

Identification and verification of EOMEs regulated network in Alopecia areata

Dissecting susceptibility from exogenous triggers: the model of alopecia areata and associated inflammatory skin diseases

Elucidating the role of T-Reg related cytokines: serum transforming growth factor beta and interleukin-35 in alopecia areata

Changes and significance of Th1/Th2 and Treg/Th17 cells and their cytokines in patients with alopecia areata

Treatment of in vitro generated Langerhans cells with JAK-STAT inhibitor reduces their inflammatory potential

Th17/Treg Balance in Peripheral Blood of Patients with Alopecia Areata